Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer. (Q36549823)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16874815%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16874815%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

cervix uterine cancer

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16874815%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Alexandra J Stewart

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16874815%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16874815%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16874815%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16874815%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16874815%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

908-915

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16874815%20AND%20SRC:MED&resulttype=core&format=json

Tumor and treatment factors improving outcome in stage III-B cervix cancer

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

Carcinoma of the cervix, stage III. Results of radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Radiation therapy for cervix carcinoma: benefits of individualized dosimetry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Comparision of four different dose specification methods for high-dose-rate intracavitary radiation for treatment of cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

The adverse effect of treatment prolongation in cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariable analysis of the effect of age, stage, histology and blood counts on survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Carcinoma of the uterine cervix: twice- versus once-weekly high-dose-rate brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Uterosacral space involvement in locally advanced carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpaşa experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: A nonrandomized comparison of treatment results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

High-dose-rate intracavitary irradiation in the treatment of carcinoma of the uterine cervix: Early experience with 84 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

High-dose-rate intracavitary brachytherapy: results of analyses of late rectal complications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Final results of Osaka University Hospital

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Long-term results of high-dose rate brachytherapy in cervix cancer using a small number of fractions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiob

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Treatment of advanced cancer of the cervix with transperineal interstitial irradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Parametrial interstitial brachytherapy for advanced or recurrent pelvic malignancy: the Harvard/Stanford experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

High dose rate transperineal interstitial brachytherapy for cervical cancer: high pelvic control and low complication rates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

A Randomized Trial of Concurrent Chemoradiotherapy versus Radiotherapy in Advanced Carcinoma of the Uterine Cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021

Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22054

7 January 2021